HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (4- (4- methyl- 6- oxo- 1,4,5,6- tetrahydropyridazin- 3- yl)phenyl)acetamide (OR 1896)

a metabolite of levosimendan; structure in first source
Also Known As:
OR 1896; (R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide; OR-1896
Networked: 9 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kivikko, Matti: 3 articles (04/2008 - 04/2004)
2. Pentikäinen, Pertti J: 3 articles (04/2008 - 04/2004)
3. Häkkinen, Sari: 2 articles (04/2008 - 01/2007)
4. Puttonen, Jaakko: 2 articles (04/2008 - 01/2007)
5. Kantele, Sampo: 2 articles (04/2008 - 01/2007)
6. Antila, Saila: 2 articles (01/2007 - 04/2004)
7. Louhelainen, Marjut: 1 article (05/2010)
8. Finckenberg, Piet: 1 article (05/2010)
9. Levijoki, Jouko: 1 article (05/2010)
10. Merasto, Saara: 1 article (05/2010)

Related Diseases

1. Heart Failure
2. Cardiomegaly (Heart Hypertrophy)
3. Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
4. Hypertension (High Blood Pressure)
5. Myocardial Infarction

Related Drugs and Biologics

1. simendan (Levosimendan)
2. N- (4- (4- methyl- 6- oxo- 1,4,5,6- tetrahydropyridazin- 3- yl)phenyl)acetamide (OR 1896)
3. Calcium
4. Connective Tissue Growth Factor
5. Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
6. Messenger RNA (mRNA)
7. Blood Glucose (Blood Sugar)
8. Aequorin
9. acetamide